I think that I would find stuff like this pretty stressful...
The [Novo Nordisk] price started to fall. Down almost 40% by end 2024, down nearly another 50%, to Kr.325, by end 2025. Then up again, to over Kr.400 by end January 2026, only to fall 25% between then and Friday last, 20 February, before falling another 16% yesterday (Monday 23 February).
I guess that there's a potential equity risk premium opportunity cost in choosing a diversified passive index tracker over direct equity holdings, but I think I'm more comfortable with the former approach myself. Others might consider even my choice too gung ho (no real cash/bonds holdings or lifestyling) but I have other assets/means that allow me to ride out volatility. I guess it just points to the fact that what's best for an individual really depends on their overall circumstances and appetite for risk/volatility...Ouch!
![]()